MaxiTears Dry Eye Formula Interactions
There are 76 drugs known to interact with MaxiTears Dry Eye Formula (omega-3 polyunsaturated fatty acids), along with 2 disease interactions. Of the total drug interactions, 76 are moderate.
- View all 76 medications that may interact with MaxiTears Dry Eye Formula
- View MaxiTears Dry Eye Formula disease interactions (2)
Most frequently checked interactions
View interaction reports for MaxiTears Dry Eye Formula (omega-3 polyunsaturated fatty acids) and the medicines listed below.
- acetaminophen
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Advair Diskus (fluticasone / salmeterol)
- amlodipine / benazepril
- aspirin
- Bayer Children's Aspirin (aspirin)
- calcium / vitamin d
- Caltrate 600+D Plus Minerals (multivitamin with minerals)
- Citracal Slow Release 1200 (calcium / vitamin d)
- Claritin (loratadine)
- CoQ10 (ubiquinone)
- Eliquis (apixaban)
- famotidine
- fenugreek
- finasteride
- Fortical (calcitonin)
- Fosamax (alendronate)
- gemfibrozil
- GenTeal (ocular lubricant ophthalmic)
- hydrochlorothiazide
- ibuprofen
- levothyroxine
- loratadine
- losartan
- metformin
- metoprolol
- Metoprolol Tartrate (metoprolol)
- montelukast
- Nasonex (mometasone nasal)
- Zetia (ezetimibe)
MaxiTears Dry Eye Formula disease interactions
There are 2 disease interactions with MaxiTears Dry Eye Formula (omega-3 polyunsaturated fatty acids) which include:
Report options
QR code containing a link to this page
More about MaxiTears Dry Eye Formula (omega-3 polyunsaturated fatty acids)
- MaxiTears Dry Eye Formula consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.